Dear Label_Name,

Greetings! I hope you are well.

I am writing on behalf of an international publishing house, Science and Education Publishing, USA (http://www.sciepub.com).

Science and Education Publishing (SciEP) is a multidisciplinary open access publisher of Journals covering the fields of Science, Technology and Medicine. All SciEP publications are subject to high-quality peer review, editorial and production processes and are freely available online.

Welcome to the April, 2013 edition of SciEP newsletter, providing monthly summaries of articles on science & education related topics of interest to scientist and professionals. The mission of our journals is to provide an open access forum for publishing new findings on issues pertinent to scientific and academic field. We also invite you to submit original research papers, review articles, short reports, or case studies are considered for publication in our Multidisciplinary Journals.

American Journal of Public Health Research
DOI: 10.12691/ajphr-1-1-3

The Implementation of a Tele-Homecare System with Service Oriented Architecture and HL7 Message Transmission Standard
Ching-Sung Wang

American Journal of Medical and Biological Research
DOI: 10.12691/ajmbr-1-1-2

The Influence of Ethanol on Pyruvate Kinases Activity in Vivo, in Vitro, in Silico
Lelevich Sergey Vladimirovich, Khrustalev Vladislav Victorovich, Barkovsky Eugene Victorovich, Shedogubova Tatyana Aleksandrovna

American Journal of Medical Sciences and Medicine
DOI: 10.12691/ajmsm-1-1-1

Clinical and Histological Features in Wegener Granulomatosis
Li Cavoli Gioacchino, Passantino Rita, Bono Luisa, Tortorici Calogera, Ferrantelli Angelo, Giammarresi Carlo, Rotolo Ugo

American Journal of Infectious Diseases and Microbiology
DOI: 10.12691/ajidm-1-1-2

The Curse of Lymphatic Filariasis: Would the Continual Use of Diethylcarbamazine Eliminate this Scourge in Papua New Guinea?
Anne Lanham, Lillian Mwanri

We have released issues of some journals on February 2013.
American Journal of Public Health Research
American Journal of Medical Sciences and Medicine
American Journal of Medical and Biological Research
American Journal of Pharmacological Sciences
American Journal of Clinical Medicine Research
American Journal of Nursing Research
American Journal of Cancer Prevention
American Journal of Medicine Studies
American Journal of Infectious Diseases and Microbiology
American Journal of Cardiovascular Disease Research
American Journal of Biomedical Research
American Journal of Mechanical Engineering
American Journal of Microbiological Research
Journal of Preventive Medicine
American Journal of Food and Nutrition
American Journal of Hypertension Research
American Journal of Sports Science and Medicine
Journal of Cancer Research and Treatment
American Journal of Zoological Research
Journal of Biomedical Engineering and Technology
American Journal of Microbiological Research
Biomedical Science and Engineering

We are pleased to announce that submissions are now being accepted for peer review for all the journals across all our subject areas in SciEP.

Please submit your manuscript via our online submission system:
http://www.sciepub.com/author/signin

To unsubscribe from our mailing list, please click on the following link: unsubscribe

I am looking forward to hearing from you.

Kind regards,

David Rain
Email:join@sciepub.com
Science and Education Publishing (http://www.sciepub.com)

Cloning Open Reading Frame (ORF) of Rv2430c Mycobacterium tuberculosis Indonesian Isolate in Escherichia coli JM 109

Rosana Agus*, Muhammad Nasrum Massi, Francisca Srioetami Tanoerahardjo

Department Of Biology, Faculty of Life Sciences, Hasanuddin University, Indonesia

Abstract: Various strategies have been implemented to prevent tuberculosis. Vaccination with Bacille Calmette Guerin (BCG) vaccine is still used around the world. Generally, most people in have gained BCG vaccine as an infant, but the effectiveness of these vaccines do not survive to adulthood. Therefore, the necessary replacement BCG vaccine more effective to eliminate tuberculosis. Mycobacterium tuberculosis is an intracellular pathogen and it was inside the macrophage, which is considered to be the most important component of the immune system. M. tuberculosis has two sets of genes are highly polymorphic referred to as PE and PPE families. These unique families of proteins account for about 10% of the mycobacterial genome and have attracted great interest from a variety of different studies around the world. One member of the as a vaccine candidate is Rv 2430c. It is known that the sera of all patients infected with TB showed strong antibody responses against Rv 2430c compared to healthy individuals. The existence of these antibodies indicates that this protein is found in vivo during infection and is a native immunogenic molecule. The purpose of this study was to clone the Open Reading Frame (ORF) Rv 2430c M. tuberculosis Indonesian isolates to host cells Esherichia coli JM 109. The method used is by isolating -chromosomal DNA from clinical isolates from Indonesia, amplifying the ORF Rv 2430c with , ligating into cloning vectors pGEM-T and transform to E.coli JM 109. Characterization of clones do with migration analysis, restriction analysis and . The results obtained are recombinant clones that carry insertion was Rv 2430cKeywords: Mycobacterium tuberculosis, Rv 2430c, ORF, , JM 109.

Keywords: mycobacterium tuberculosis, Rv 2430c, vaccine

Citation: Rosana Agus, Muhammad Nasrum Massi, Francisca Srioetami Tanoerahardjo, Cloning Open Reading Frame (ORF) of Rv2430c Mycobacterium tuberculosis Indonesian Isolate in Escherichia coli JM 109. American Journal of Biomedical Research, 4 (4). 99-101. January 2016. doi:10.12691/ajbr-4-4-4

1. Introduction

Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), is responsible for 9 million new cases of active TB and 1–1.5 million deaths annually [1]. It is estimated that nearly 2 billion people suffer from latent TB around the world, which potentially become an active TB. The only vaccine currently used is BCG, which has been developed since almost a century ago. BCG is given in newbornes routinely in TB endemic countries. However, the effectiveness of BCG was reduced in adolescents, and the vaccine does not consistently prevent the development of active pulmonary TB in adults (efficacy estimated between 0 and 80% with the lowest efficacy rates often found in countries with the highest burden of TB) [2,3,4]. Thus, there is an urgent need for a new TB vaccine to either boost immunity primed by BCG or replace BCG [5,6].

The variation in sequence and length of C-terminal region among members of the unique PE (Pro-Glu) and (Pro-Pro-Glu) protein families of Mycobacterium tuberculosis is a likely source of antigenic variation. Based on in-silico analysis, we selected a hypothetical open reading frame (ORF) encoding a protein belonging to the family and having epitopes with predictably higher antigenic indexes. Reverse transcriptase from in vitro-cultured M. tuberculosis H37Rv generated an mRNA product corresponding to this gene, which is indicating the expression of this ORF (Rv2430c) at the mRNA level. Our results reveal that this ORF induces a strong B-cell response compared to that generated by M. tuberculosis Hsp10 or , pointing to the immunodominant nature of the protein [7].

Cloning of ORF Rv 2430 performed on pGEM-T cloning vector and host Escherichia. coli JM 109. It is expected that this gene can be used as candidate antigens for TB vaccine search.

2. Materials and Methods

2.1. Bacterial Strains and Plasmids

The cloning vectors pGEM-T Easy (Promega) was used. The strains M. tuberculosis was obtained from clinical isolate from Indonesia. E. coli JM 109 was obtained from Center For Biomedical and Basic Technology of Health.

2.2. Culture Condition

The E. coli JM 109 were incubate with stirring over night in LB medium in the presence of ampicillin (1μg/ml) at 37°C. E.coli JM109 competent cells prepared in advance by the CaCl2 method [8] modified.

2.3. PCR

The following primer was design by [7]

Rev 5’-AAGCTTCTAAGTGTCTGTACGCGATGA-3’

Fwd 5’-GGATCCATGCATTTCGAAGCGTAC-3’

The reactions were performed with 1 μl of template in a total volume of 25 μl. Generally, the profiles consisted of a hot start at 94°C, an initial denaturation at 94°C for 1 minute, a denaturation at 94°C for 30 second, an annealing at 55°C for 1 minute and an extension step at 72°C for 40 second. After 25 cycles an extension was carried out at 72°C for 7 minutes. products were examined by agarose gel electrophoresis and staining with ethidium bromide.

2.4. Transformation

Isolation of DNA and transformation of the E. coli JM 109 cells were performed as described in the guidebook [8], with the following modifications. Transformed cells were spread on the appropriate indicator plates containing ampicillin. Colonies were scored for phenotype on Luria Bertani agar plates after 24 hours at 37°C.

2.5. Creation of Plasmids of the Recombinant Rv 2430c in E. coli JM 109

Fragment of the ORF Rv 2430c were obtained by using two primers pair and DNA of the M. tuberculosis Indonesian strain as a template. The pGEM-T vector and PCR product were cut with BamHI and HindIII, mixed, and treated with T4 DNA ligase. The resulting recombinant plasmid pGEM-T-Rv2430c was transformed in E. coli JM 109.

Figure 1. Ligation scheme of ORF Rv2430c into cloning vector pGEM T-Easy

3. Results and Discussion

3.1. PCR Product and Purification

The results of amplification of ORF Rv 2430 observed by electrophoresis agarosa. A band was revealed which corresponded to the gene with the apparent of 597 bp. It is appropriate that obtained Choudhary et al, 2003 that 597bp band was observed upon staining with ethidium bromide, indicating that the ORF was expressed at the mRNA level in the liquid cultures of M. tuberculosis

Figure 2. Purification of product: 1) Marker 100 bp, 2) ORF Rv 2430c

3.2. Characterization of Recombinant Plasmid of pGEM-T-Rv 2430c

Isolation of plasmid were performed according to the procedure instructions (BioRad). Characterization was done by migration analysis, restriction analysis, and PCR analysis. Migration analysis was done by comparing pGEM-T (3000bp) and pGEM-T-Rv 2430c (3597bp). A band shows difference length while pGEM-T-Rv2430c had slower migration than pGEM-T (Figure 3).

Figure 3. Migration analysis: 1) pGEM-T: 3000 bp, 2) pGEM-T-Rv2830: 3597bp

This suggests that the plasmid without insert (pGEM-T) will move faster than the recombinant plasmid (pGEM-T-Rv 2430). This means that the inserts ORF Rv 2430 has been successfully ligation into the vector pGEM-T.

Restriction analysis was done using 2 restriction enzymes BamHI and HindIII in pGEM-T-Rv2430c. By electrophoresis, a linier band was showed a different shape with uncut recombinant plasmid which has supercoiled and relaxed band (Figure 4).

Figure 4. Restriction analysis: 1) pGEM-T-Rv2430c (3597bp) uncut; 2) pGEM-T-Rv2430c (3597bp) cut; 3) Marker 1 kb

Uncut plasmids can be in two forms: relaxed and supercoiled (or superhelical). The lane with the digested plasmid has a single band, while the lane with the undigested sample has three bands. If the lower band had moved most rapidly because it was a smaller fragment than the others, then we would expect that it would be much dimmer than the others because, in general, less fluorescent dye is intercolated by smaller fragments. However, in this case the lower band is much brighter than the other bands, either because the supercoiled shape holds dye better or because a higher fraction of the molecules in that lane were in the supercoiled form than in other forms [9].

analysis was done by using exactly the same cycle as it mentioned before for amplified the Rv 2430c gene. Electrophoresis showed that plasmid recombinant pGEM-T-Rv2430c contain the Rv 2430c gene as DNA insert was 597 bp (Figure 5).

Figure 5. analysis: 1) Rv 2430c :597bp 2) Marker 100 bp

4. Conclusion

Cloning ORF of Rv 2430c M. tuberculosis Indonesia isolates to Escherichia coli JM 109 has been successfully and characterized insert by , migration analysis and restriction analysis.

Acknowledgments

The authors would like to thank Kemenristek Dikti and Center for Biomedical and Basic Technology of Health, which has funded this research through a Consortium of TB Vaccine.

References

[1]   | World Health Organization. Global tuberculosis report, World Health Organization, Geneva, 2013.

[2]  
Abubakar, I., L. Pimpin, C. Ariti, R. Beynon, P. Mangtani, J. A. Sterne, P. E. Fine, P. G. Smith, M. Lipman, D. Elliman, et al. Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Gue´rin vaccination against tuberculosis. Health Technol. Assess.17: 1-372, v–vi, 2013.

[3]   | Hart, P. D., and I. Sutherland. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. BMJ 2: 293-295, 1977
[4]   | Baily, G. V. 1980. Tuberculosis prevention Trial, Madras. Indian J. Med. Res. 72 (Suppl.): 1-74, 1980.
[5]   | Brennan, M. J., and J. Thole. Tuberculosis vaccines: a strategic blueprint for the next decade. Tuberculosis (Edinb.) 92(Suppl. 1): S6-S13, 2012.
[6]   | Checkley, A. M., and H. McShane. Tuberculosis vaccines: progress and challenges. Trends Pharmacol. Sci. 32: 601-606, 2011.
[7]   | Choudhary R.K, Sangita Mukhopadhyay, Prachee Chakhaiyar, Naresh Sharma, K.J.R Murthy, V.M Katoch and Seyed E. Hasnain, PPE antigen Rv 2430 c of Mycobacterium tuberculosis induces a strong B- cell Response, Infection and Immunity, Vol 71 No 11, p.6338-6343, 2003.
[8]   | Sambrook, J., Fristch, E.F. dan Maniatis, T. Molecular Cloning A Laboratory Manual. Cold Spring Harbor Laboratory Press, 1989.
[9]   | Jean and Alexander Heard Library, 2016, BSCI 1510l: Detecting uncut Plasmids from the Restriction Digests.